RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/32219447http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/32219447http://www.w3.org/2000/01/rdf-schema#comment"Acute myeloid leukemia (AML) with inv(3)/t(3;3)(q21q26) is a distinct World Health Organization recognized entity, characterized by its aggressive course and poor prognosis. In this subtype of AML, the translocation of a GATA2 enhancer (3q21) to MECOM (3q26) results in overexpression of the MECOM isoform EVI1 and monoallelic expression of GATA2 from the unaffected allele. The full-length MECOM transcript, MDS1-EVI1, is not expressed as the result of the 3q26 rearrangement. Besides the classical inv(3)/t(3;3), a number of other 3q26/MECOM rearrangements with poor treatment response have been reported in AML. Here, we demonstrate, in a group of 33 AML patients with atypical 3q26 rearrangements, MECOM involvement with EVI1 overexpression but no or low MDS1-EVI1 levels. Moreover, the 3q26 translocations in these AML patients often involve superenhancers of genes active in myeloid development (eg, CD164, PROM1, CDK6, or MYC). In >50% of these cases, allele-specific GATA2 expression was observed, either by copy-number loss or by an unexplained allelic imbalance. Altogether, atypical 3q26 recapitulate the main leukemic mechanism of inv(3)/t(3;3) AML, namely EVI1 overexpression driven by enhancer hijacking, absent MDS1-EVI1 expression and potential GATA2 involvement. Therefore, we conclude that both atypical 3q26/MECOM and inv(3)/t(3;3) can be classified as a single entity of 3q26-rearranged AMLs. Routine analyses determining MECOM rearrangements and EVI1 and MDS1-EVI1 expression are required to recognize 3q-rearranged AML cases."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.org/dc/terms/identifier"doi:10.1182/blood.2019003701"xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Smeenk L."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Delwel R."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Valk P.J.M."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Beverloo H.B."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"van der Helm R."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Haferlach T."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Haferlach C."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Erpelinck C."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Bindels E."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Grob T."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Havermans M."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Mulet-Lazaro R."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"Ottema S."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/author"van Herk S."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/date"2020"xsd:gYear
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/name"Blood"xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/pages"224-234"xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/title"Atypical 3q26/MECOM rearrangements genocopy inv(3)/t(3;3) in acute myeloid leukemia."xsd:string
http://purl.uniprot.org/citations/32219447http://purl.uniprot.org/core/volume"136"xsd:string
http://purl.uniprot.org/citations/32219447http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/32219447
http://purl.uniprot.org/citations/32219447http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/32219447
http://purl.uniprot.org/uniprot/#_A0A0C3SFZ7-mappedCitation-32219447http://www.w3.org/1999/02/22-rdf-syntax-ns#objecthttp://purl.uniprot.org/citations/32219447